New Key Statistics Module, Z-Score and F-Score
OHEL:OPTOMED Key Ratios
Market Cap € M | 100.72 |
Enterprise Value € M | 92.74 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.68 |
Price/Sales | 5.88 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) € M | 14.00 |
EPS (TTM) € | -0.28 |
Beneish M-Score | -3.47 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -21.82 |
EV-to-EBITDA | -48.61 |
PEG | -- |
Shares Outstanding M | 19.60 |
Net Margin (%) | -32.98 |
Operating Margin % | -33.86 |
Pre-tax Margin (%) | -33.47 |
Quick Ratio | 2.67 |
Current Ratio | 3.16 |
ROA % (ttm) | -16.17 |
ROE % (ttm) | -23.26 |
ROIC % (ttm) | -26.35 |
Dividend Yield % | -- |
Altman Z-Score | 6.46 |
OHEL:OPTOMED Number of Guru Trades
OHEL:OPTOMED Volume of Guru Trades
Gurus Latest Trades with OHEL:OPTOMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OHEL:OPTOMED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data